Mitral Valve Annuloplasty Rings Market is Segmented By Product Type (Rigid/Semi-rigid Rings, Flexibl...
Market Size in USD Bn
CAGR5.5%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 5.5% |
Market Concentration | High |
Major Players | Abbott Laboratories, Medtronic plc, Edwards Lifesciences Corporation, LivaNova PLC, Braun Melsungen AG and Among Others |
The Mitral Valve Annuloplasty Rings Market is estimated to be valued at USD 0.97 Billion in 2025 and is expected to reach USD 1.41 Billion by 2032, growing at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2032. The increasing prevalence of valvular heart diseases globally due to the rising geriatric population and the growth in technological advancements are expected to propel the demand for Mitral Valve Annuloplasty Rings over the forecast period.
The Mitral Valve Annuloplasty Rings Market is expected to witness positive growth over the next few years. Rising rates of mitral regurgitation due to the growing elderly population base are raising the demand for mitral valve repair surgeries. Additionally, the development of innovative repair devices such as flexible rings and undersized rings is fueling adoption. However, the high cost of surgeries and device complexity remain challenges to Market growth.